FONT-SIZE Plus   Neg

Blinkx Sees Annual Revenues Of $245 Mln - $247 Mln - Quick Facts

Blinkx Plc (BLNX.L), in its trading update for fiscal 2014, said it expects revenues to be in the range of $245 million - $247 million and adjusted EBITDA of $37 million - $39 million, in line with market view.

As announced earlier, the company would host a Capital Markets Day for Institutional Investors and Analysts in London today, which would include presentations by both the company and representatives from the online advertising ecosystem, followed by a panel discussion.

Today, blinkx also published a detailed response to a blog post dated January 28, 2014, that questioned its business model and practices. blinkx strongly refuted the assertions made in the blog at the time it was published.

"We are pleased with the performance of the business in FY2014, particularly with the successful integration of Rhythm in mobile video, despite the obvious distractions in the last quarter of the financial year," said Brian Mukherjee, Chief Executive Officer of blinkx.

The company expects to announce its fiscal 2014 results on May 6, 2014.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Apple confirmed that it has bought face animation software firm Faceshift, although it was tight lipped about how it intends to use the new addition. The move is speculated as a bid to expand into virtual reality. Environment ministry of South Korea Thursday ordered Volkswagen Korea to recall 125,522 diesel vehicles on determining actual emissions of nitrogen oxides. The ministry has asked the German automobile maker to pay a fine of 14.1 billion Won or $12.31 million. The company has to submit a recall plan by January 6, 2016. The U.S. Food and Drug Administration has alerted health care professionals and patients of a voluntary recall of compounded multivitamin capsules containing high amounts of Vitamin D3 (Cholecalciferol), distributed nationwide by Glades Drugs in Pahokee, Florida. FDA has received reports of several...
comments powered by Disqus
Follow RTT